Volitionrx (VNRX) Cash from Investing Activities Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.96% |
| Jun 30, 2025 | 22.04% |
| Mar 31, 2025 | 64.72% |
| Dec 31, 2024 | -5.45% |
| Sep 30, 2024 | -2.19% |
| Jun 30, 2024 | -5.17% |
| Mar 31, 2024 | 6.81% |
| Dec 31, 2023 | -21.16% |
| Sep 30, 2023 | -36.31% |
| Jun 30, 2023 | -35.97% |
| Mar 31, 2023 | -27.02% |
| Dec 31, 2022 | -46.77% |
| Sep 30, 2022 | -25.31% |
| Jun 30, 2022 | -8.50% |
| Mar 31, 2022 | 32.28% |
| Dec 31, 2021 | 16.96% |
| Sep 30, 2021 | -46.45% |
| Dec 31, 2020 | -158.07% |
| Sep 30, 2020 | 36.01% |
| Jun 30, 2020 | -43.42% |
| Mar 31, 2020 | -35.16% |
| Dec 31, 2019 | -95.00% |
| Sep 30, 2019 | 13.34% |
| Jun 30, 2019 | -34.25% |
| Mar 31, 2019 | -44.06% |
| Dec 31, 2018 | -934.12% |
| Sep 30, 2018 | -796.87% |
| Mar 31, 2018 | -143.13% |
| Dec 31, 2017 | -34.78% |
| Sep 30, 2017 | -197.11% |
| Jun 30, 2017 | -60.96% |
| Mar 31, 2017 | -87.46% |
| Dec 31, 2016 | -99.37% |
| Sep 30, 2016 | -0.77% |